Search results
Results from the WOW.Com Content Network
The scientific focus of Fazekas is neuroimaging using magnetic resonance imaging, multiple sclerosis, stroke, and dementia.Fazekas suggested a scale to grade white-matter hyperintensities, which was later named the Fazekas scale and is used worldwide in neurology and neuroradiology. [3]
Ischaemic leukoaraiosis has been defined as the leukoaraiosis present after a stroke. [12]Diabetes-associated leukoaraiosis has been reported [13]; CuRRL syndrome: increased Cup: Disc Ratio, Retinal GanglionCell Complex thinning, Radial Peripapillary Capillary Network Density Reduction and Leukoaraiosis [2]
The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS), is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke and aid planning post-acute care disposition, though was intended to assess differences in interventions in clinical trials. The NIHSS was designed for the National ...
The acronym was created to expedite administration of intravenous tissue plasminogen activator to patients within 3 hours of acute stroke symptom onset. The instruments at this time with most evidence of validity were the Cincinnati Prehospital Stroke Scale (CPSS) and the Los Angeles Prehospital Stroke Screen (LAPSS). [3]
The Cincinnati Prehospital Stroke Scale (abbreviated CPSS) is a system used to diagnose a potential stroke in a prehospital setting. [1] It tests three signs for abnormal findings which may indicate that the patient is having a stroke.
The suspect in the truck attack that killed 14 and injured dozens in New Orleans on New Year's had traveled to Egypt in 2023 for about a month, his half-brother told ABC News. Shamsud-Din Jabbar ...
Cerebral infarction, also known as an ischemic stroke, is the pathologic process that results in an area of necrotic tissue in the brain (cerebral infarct). [1] In mid to high income countries, a stroke is the main reason for disability among people and the 2nd cause of death. [2]
Fugl-Meyer Assessment (FMA) scale is an index to assess the sensorimotor impairment in individuals who have had stroke. [1] This scale was first proposed by Axel Fugl-Meyer and his colleagues as a standardized assessment test for post-stroke recovery in their paper titled The post-stroke hemiplegic patient: A method for evaluation of physical performance.